Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer
Authors
Keywords
-
Journal
Clinical Respiratory Journal
Volume 12, Issue 2, Pages 712-720
Publisher
Wiley
Online
2016-11-18
DOI
10.1111/crj.12584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma
- (2016) Hai-Ying Zou et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival
- (2015) S. Torres et al. CLINICAL CANCER RESEARCH
- Non–Small Cell Lung Cancer, Version 6.2015
- (2015) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
- (2014) Hiroaki Kasashima et al. CANCER LETTERS
- LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients
- (2013) Sung Gwe Ahn et al. BREAST CANCER RESEARCH AND TREATMENT
- Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression
- (2013) Long Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
- (2011) H. E. Barker et al. CANCER RESEARCH
- Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase–like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma
- (2011) Tian-Yu Li et al. HUMAN PATHOLOGY
- Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas
- (2011) Ping Zhan et al. MEDICAL ONCOLOGY
- Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
- (2010) Jun Hou et al. PLoS One
- Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway
- (2009) Liang Peng et al. CARCINOGENESIS
- Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells
- (2009) Peter Hollosi et al. INTERNATIONAL JOURNAL OF CANCER
- Functional analysis of LOXL2 in pancreatic carcinoma
- (2009) Felix Rückert et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
- (2008) H. Peinado et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More